Concepedia

P Lyn

PL

Statistics

Publications

7

Citations

721

H-Index

7

Active since

1993

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

P Lyn is an author at Memorial Sloan Kettering Cancer Center specializing in hematology, immunology, and tumor biology.

Top concepts

Publications per year

1993–1997

7

Publications

7

Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.

Robert J. Motzer, Dean F. Bajorin, Lawrence H. Schwartz et al. · Journal of Clinical Oncology · 1994 · 174 citations

Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors

Robert J. Motzer, Madhu Mazumdar, Subhash C. Gulati et al. · JNCI Journal of the National Cancer Institute · 1993 · 155 citations

High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.

Robert J. Motzer, Madhu Mazumdar, Dean F. Bajorin et al. · Journal of Clinical Oncology · 1997 · 154 citations

Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.

Robert J. Motzer, P Lyn, P Fischer et al. · Journal of Clinical Oncology · 1995 · 79 citations

Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors.

Robert J. Motzer, Joel Sheinfeld, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1995 · 77 citations

1–5 of 7